The Role of Liver Biopsy Findings in Uncontrolled Donation After Circulatory Death a 4-Year Single-Center Experience

Luca Novelli1, Chiara Lazzeri2, Davide Ghinolfi3

  • 1Institute of Histopathology and Molecular Diagnosis, Careggi University Hospital, Florence, Italy.

Clinical Transplantation
|January 6, 2026
PubMed

Insights

Liver biopsies in uncontrolled donors after circulatory death (uDCDs) reveal common steatosis and mild inflammation, offering insights into donor health and potential ischemic-reperfusion injury. These findings aid in assessing donor liver suitability for transplantation.

Area of Science:

  • Transplantation immunology
  • Organ procurement
  • Hepatology

Background:

  • Uncontrolled donors after circulatory death (uDCDs) represent a significant, yet underutilized, donor pool.
  • Limited data exists on the histopathological characteristics of livers from uDCDs.
  • This study addresses the gap by examining liver biopsy findings in uDCDs.

Purpose of the Study:

  • To evaluate the histopathological features of liver biopsies obtained from uncontrolled donors after circulatory death (uDCDs).
  • To determine the prevalence of steatosis, inflammation, and ischemic-reperfusion injury in uDCD livers.
  • To assess the potential of liver biopsy to inform donor liver suitability and understand donor-related factors.

Main Methods:

  • A consecutive series of 29 utilized uncontrolled donors after circulatory death (uDCDs) admitted between 2019 and 2023 were included.
  • Liver biopsies were performed during the organ procurement procedure for all included donors.
  • Standard histopathological assessment including Ishak grading and evaluation for steatosis and injury was conducted.

Main Results:

  • The median time from cardiac arrest to normothermic regional perfusion (NRP) was 144 minutes, with a median NRP duration of 6 hours.
  • Livers were retrieved but not transplanted in 41% (12/29) and transplanted in 35% (10/29) of cases; 24% (7/29) were not retrieved.
  • The majority of biopsies showed mild steatosis (microsteatosis <50% in 82%, macrosteatosis <30% in 76%) and mild inflammation (Ishak grade 1-2 in 72%), with severe ischemic-reperfusion injury (IRI) noted in 16% (4/24).

Conclusions:

  • Liver biopsies in uDCDs provide crucial information regarding chronic damage (steatosis, Ishak score) and acute injury (ischemic-reperfusion injury).
  • These histopathological findings can assist clinicians in evaluating the suitability of uDCD livers for transplantation.
  • The biopsy data may also offer insights into the impact of the uDCD process and donor comorbidities on liver quality.
Abstract